|
|
| TAK-940 / Takeda, Memorial Sloan-Kettering Cancer Center (0 Trials) |
|
| TAK-951 / Takeda (0 Trials) |
|
| TAK-960 / Takeda (0 Trials) |
|
| TAK-988 / Takeda (0 Trials) |
|
| TAK-994 / Takeda (0 Trials) |
|
| TAKC-02 / TAK-Circulator (0 Trials) |
|
| Takecab (vonoprazan) / Takeda, Phathom Pharma (90 Trials) |
|
| Takhzyro (lanadelumab-flyo) / Takeda (2 Trials) |
|
| takinib (EDHS-206) / Duke University (0 Trials) |
|
| Taksta (fusidic acid) / Idera (1 Trials) |
|
| TAK‐632 / Takeda (0 Trials) |
|
| talabostat (BXCL701) / BioXcel (0 Trials) |
|
| talacotuzumab (JNJ-56022473) / J&J (1 Trials) |
|
| talactoferrin oral (oral rhLF) / Agennix (0 Trials) |
|
| taladegib (ENV 101) / Endeavor BioMed (1 Trials) |
|
| taldefgrobep alfa (BHV-2000) / Biohaven (0 Trials) |
|
| taletrectinib (AB-106) / Baoyuan Biopharma, Innovent Biologics, Nippon Kayaku (4 Trials) |
|
| TALGlobin01 / Cellectis (0 Trials) |
|
| Talicia (amoxicillin/omeprazole/rifabutin) / RedHill (0 Trials) |
|
| TaliCoVaX 19 / Innomedica (0 Trials) |
|
| Talidox (doxorubicin liposomal) / Innomedica (0 Trials) |
|
| Talineuren (liposomal GM1) / Innomedica, TRB Chemedica (0 Trials) |
|
| talmapimod (SCIO-469) / J&J (0 Trials) |
|
| Taltorvic (ridaforolimus) / Takeda, Merck (MSD) (2 Trials) |
|
| Taltz (ixekizumab) / Eli Lilly, Japan Tobacco (20 Trials) |
|
| Talvey (talquetamab-tgvs) / J&J (0 Trials) |
|
| Talzenna (talazoparib) / Pfizer (61 Trials) |
|
| TAM-01 / Mount Tam (0 Trials) |
|
| tamgiblimab (IBI-939) / Innovent Biologics (0 Trials) |
|
| Tamid-001 / Fortress (0 Trials) |
|
| Tamin (paracetamol) / Baxter Healthcare (0 Trials) |
|
| taminadenant (NIR178) / Novartis (0 Trials) |
|
| tamnorzatinib (ONO-7475) / Ono Pharma (2 Trials) |
|
| tamoxifen / Generic mfg. (192 Trials) |
|
| tamoxifen vaginal (DARE-VVA1) / Daré Biosci (0 Trials) |
|
| tamrintamab pamozirine (SC-003) / AbbVie (1 Trials) |
|
| tamsulosin / Generic mfg. (66 Trials) |
|
| tamsulosin prolonged release / Generic mfg. (0 Trials) |
|
| Tanatril (imidapril) / Chiesi, GL PharmTech, Mitsubishi Tanabe (0 Trials) |
|
| tandutinib (MLN518) / Takeda (0 Trials) |
|
| tanespimycin (BMS-722782) / BMS (0 Trials) |
|
| tanfanercept (HL036) / Daewoong Pharma (2 Trials) |
|
| taniborbactam (VNRX-5133) / VenatoRx (0 Trials) |
|
| tanimilast (CHF6001) / Chiesi (3 Trials) |
|
| taniraleucel (CYNK-001) / Celularity, United Therapeutics Corp (0 Trials) |
|
| Tantum (benzydamine) / Elder Pharma (0 Trials) |
|
| Tantum Gel (benzydamine) / Elder Pharma (0 Trials) |
|
| Tanzeum (albiglutide) / GSK (1 Trials) |
|
| tanzisertib (CC 930) / BMS (0 Trials) |
|
| TAP 311 / Novartis (0 Trials) |
|
| Tapit (granisetron) / VHB Life Sci (0 Trials) |
|
| taplucanium nebulizer (NOC-100) / Nocion Therap (0 Trials) |
|
| tapotoclax (AMG 176) / Amgen (0 Trials) |
|
| Taptiqom (tafluprost/timolol) / Santen, AGC Biologics (1 Trials) |
|
| taragarestrant (D-0502) / InventisBio (0 Trials) |
|
| tarcocimab tedromer (KSI 301) / Kodiak Sciences (0 Trials) |
|
| tarenflurbil (MK-50) / Nogra Pharma (0 Trials) |
|
| tarextumab (OMP-59R5) / MorphoSys, Mereo Biopharma (0 Trials) |
|
| TARG-ALLERG I-200 (interleukin 13) / Targepeutics (0 Trials) |
|
| TARG10 / Xintela (0 Trials) |
|
| TARG9 / Xintela (0 Trials) |
|
| Target lost antigens cell therapies / A2 Biotherap (0 Trials) |
|
| Target-11 / Cerevance (0 Trials) |
|
| Target-16 / Cerevance (0 Trials) |
|
| Target-17 / Cerevance (0 Trials) |
|
| Target-18 / Cerevance (0 Trials) |
|
| target-activated natural killer cell therapy / ImmunityBio (0 Trials) |
|
| targetaSN / Evotec (0 Trials) |
|
| Targeted Fragile X Syndrome therapeutic / Vencerx Therap (0 Trials) |
|
| targetPicV / Bayer, Evotec, Horizon Discovery (0 Trials) |
|
| Targets for cardiovascular disease / Merck (MSD) (0 Trials) |
|
| TargomiR (EGFREDVmiR-16) / EnGeneIC, Asbestos Diseases Research Institute (1 Trials) |
|
| Targretin gel (bexarotene topical) / Eisai, Bausch Health (1 Trials) |
|
| Targretin oral (bexarotene oral) / ReXceptor (5 Trials) |
|
| tarlatamab (AMG 757) / Amgen (0 Trials) |
|
| Tarlige (mirogabalin) / Daiichi Sankyo (2 Trials) |
|
| Tarlox (tarloxotinib bromide) / Pathos (2 Trials) |
|
| Tarmogen (GI-5005) / GlobeImmune (0 Trials) |
|
| TARP dendritic cell vaccine / PDS Biotech (0 Trials) |
|
| tarperprumig (ALXN1820) / AstraZeneca (0 Trials) |
|
| Tarpeyo (budesonide) / Calliditas, Stada (2 Trials) |
|
| Tarvacin (bavituximab) / OncXerna Therap (2 Trials) |
|
| TAS-108 / Otsuka, Nobelpharma, SRI International (0 Trials) |
|
| TAS-114 / Otsuka (0 Trials) |
|
| TAS-121 / Otsuka (0 Trials) |
|
| TAS-2913 / Otsuka (0 Trials) |
|
| TAS-2985 / Otsuka (0 Trials) |
|
| TAS-303 / Otsuka (0 Trials) |
|
| TAS0286 / Otsuka, Helsinn (0 Trials) |
|
| TAS0313 / Otsuka (0 Trials) |
|
| TAS05567 / Otsuka (0 Trials) |
|
| TAS0612 / Otsuka (0 Trials) |
|
| TAS0728 / Otsuka (1 Trials) |
|
| TAS1440 / Otsuka (0 Trials) |
|
| TAS1553 / Otsuka (0 Trials) |
|
| TAS2940 / Otsuka (0 Trials) |
|
| TAS3351 / Otsuka (0 Trials) |
|
| TAS3681 / Otsuka (1 Trials) |
|
| TAS4464 / Otsuka (0 Trials) |
|
| TAS5315 / Otsuka (0 Trials) |
|
| tasadenoturev (DNX-2401) / DNAtrix (3 Trials) |
|
| taselisib (GDC-0032) / Roche (4 Trials) |
|
| Tasigna (nilotinib) / Novartis, Inhibikase (65 Trials) |
|
| tasisulam (LY573636) / Eli Lilly (0 Trials) |
|
| TASP0277308 / Taisho (0 Trials) |
|
| TASP0412098 / Taisho (0 Trials) |
|
| taspoglutide (BIM51077) / Ipsen (0 Trials) |
|
| tasquinimod (ABR-215050) / Active Biotech, Ipsen (3 Trials) |
|
| tasurgratinib (E7090) / Eisai (1 Trials) |
|
| Tat Oyi / Biosantech (0 Trials) |
|
| TatImmune (tat protein based HIV vaccine) / Vaxxit (0 Trials) |
|
| TATX-03 / ImmunoPrecise (0 Trials) |
|
| TATX-112 / ImmunoPrecise (0 Trials) |
|
| tau inhibitor / APRINOIA Therap (0 Trials) |
|
| Tauferon (IFN-τ) / Pepgen Corp (0 Trials) |
|
| Tavalisse (fostamatinib) / Rigel, Grifols (12 Trials) |
|
| tavapadon (CVL-751) / Cerevel Therap (3 Trials) |
|
| Tavegil (clemastine) / GSK (0 Trials) |
|
| TAvi6 / Roche (0 Trials) |
|
| tavilermide (MIM-D3) / Mimetogen (0 Trials) |
|
| Tavin-LN kit (tenofovir/lamivudine/nevirapine) / Emcure (0 Trials) |
|
| Tavneos (avacopan) / Amgen (3 Trials) |
|
| Tavo (tavokinogene telsaplasmid) / OncoSec (3 Trials) |
|
| TAVO101 / Tavotek (0 Trials) |
|
| Tavo103 / Tavotek (0 Trials) |
|
| Tavo111 / Tavotek (0 Trials) |
|
| TAVO412 / Tavotek (0 Trials) |
|
| Tavocept (dimesna) / BioNumerik, Lantern Pharma (1 Trials) |
|
| tavolixizumab (MEDI0562) / AstraZeneca (2 Trials) |
|
| TAVT-135 / Tavanta Therap (0 Trials) |
|
| Taxoprexin (DHA-paclitaxel) / Daiichi Sankyo (0 Trials) |
|
| Taxosomes (paclitaxel nanosomal) / Aphios (0 Trials) |
|
| TAY018 / TOT Biopharm (0 Trials) |
|
| tazarotene oral (GRI-0621) / GRI Bio (1 Trials) |
|
| tazarotene topical / Generic mfg. (3 Trials) |
|
| Tazverik (tazemetostat) / Eisai, Ipsen (34 Trials) |
|
| TB-100 / Therabest (0 Trials) |
|
| TB-101 / Peptron, Therabest (0 Trials) |
|
| TB-200 / Therabest (0 Trials) |
|
| TB-201 / Therabest, Peptron (0 Trials) |
|
| TB-219 / Therabest (0 Trials) |
|
| TB-301 / Therabest (0 Trials) |
|
| TB-402 / Y's Therap (0 Trials) |
|
| TB-403 / Oxurion (0 Trials) |
|
| TB-840 / Therasid Biosci (0 Trials) |
|
| TB-ADC-01 / Theragen Bio (0 Trials) |
|
| TB-ADC-02 / Theragen Bio (0 Trials) |
|
| TB-CV-01 / Theragen Bio (0 Trials) |
|
| TB-CV-02 / Theragen Bio (0 Trials) |
|
| TB-SM-01 / Theragen Bio (0 Trials) |
|
| TB006 / TrueBinding (0 Trials) |
|
| TB31F / Radboud University, PATH (0 Trials) |
|
| TBA-7371 / Bill & Melinda Gates Foundation, Global Alliance for TB Drug Development, Foundation for Neglected Disease Research (0 Trials) |
|
| TBAJ-876 / Global Alliance for TB Drug Development (0 Trials) |
|
| TBI 1201 / Takara (0 Trials) |
|
| TBI 302 / Resilience (0 Trials) |
|
| TBI-1501 / Otsuka (1 Trials) |
|
| TBI-2002 / Takara (0 Trials) |
|
| TBI-223 / Global Alliance for TB Drug Development (0 Trials) |
|
| TBio-6517 / Turnstone Biologics (0 Trials) |
|
| TBL-100 / TauC3 Bio (0 Trials) |
|
| TBS-3 / Acerus (0 Trials) |
|
| TBS-5 / Acerus (0 Trials) |
|
| TBX-03 / TheraBiologics (0 Trials) |
|
| TBX-1400 / Taiga Biotech (1 Trials) |
|
| TBX-2400 / Taiga Biotech (0 Trials) |
|
| TBX-3400 / Taiga Biotech (0 Trials) |
|
| TC 7020 / Catalyst Biosci (0 Trials) |
|
| TC-110 / Adaptimmune (0 Trials) |
|
| TC-2429 / Catalyst Biosci (0 Trials) |
|
| TC-310 / Adaptimmune (0 Trials) |
|
| TC-510 / Adaptimmune (0 Trials) |
|
| TC-6987 / Catalyst Biosci (0 Trials) |
|
| TC-8831 / Catalyst Biosci (0 Trials) |
|
| TC-A101 / TCRCure (0 Trials) |
|
| TCB003 / TC Biopharm, NIPRO Corp (0 Trials) |
|
| TCB004 / TC Biopharm, Regeneron (0 Trials) |
|
| TCB005 / TC Biopharm (0 Trials) |
|
| TCB006 / TC Biopharm (0 Trials) |
|
| TCB009 / TC Biopharm (0 Trials) |
|
| TCC1727 / Sino Biopharm (0 Trials) |
|
| tCellVax / Regen BioPharma (0 Trials) |
|
| Tcelna (imilecleucel-T) / EMD Serono, Zevra Therap (0 Trials) |
|
| TCK-276 / Teijin (0 Trials) |
|
| TCM-606F / TCM Biotech (0 Trials) |
|
| TCMCB07 / Endevica, WuXi AppTec (0 Trials) |
|
| TCN-202 / Theraclone Sciences (0 Trials) |
|
| TCR discovery for stem to T-cell program / EOM Pharma (0 Trials) |
|
| TCR-based therapy / Engimmune (0 Trials) |
|
| TCR-deficient NKR T-cell therapy / Celyad Oncology (0 Trials) |
|
| TCR-NK-X / Karolinska Institute, Zelluna (0 Trials) |
|
| TCR-T cell immunotherapy / National University of Singapore (0 Trials) |
|
| TCRT-ESO-A2 / Axis Therap (0 Trials) |
|
| TCRx_T / TCRx Therap, Zhejiang University (0 Trials) |
|
| TD-0714 / Theravance Biopharma (0 Trials) |
|
| TD-1058 / Theravance Biopharma (0 Trials) |
|
| TD-1211 / Innoviva (0 Trials) |
|
| TD-1439 / Theravance Biopharma (0 Trials) |
|
| TD-1607 / Theravance Biopharma (0 Trials) |
|
| TD-6450 / Innoviva, Trek Therapeutics (0 Trials) |
|
|